Neurophysiological Mechanisms Involved in Knee Osteoarthritis
NCT ID: NCT03556423
Last Updated: 2022-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
28 participants
OBSERVATIONAL
2018-07-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Phenotypes in Knee Osteoarthritis
NCT02664896
The Effect of Central Sensitization and Neuropathic Pain After Total Knee Arthroplasty
NCT05581836
Effects of Motor Imagery Intervention on Functional Recovery Following Total Knee Arthroplasty
NCT03684148
The Relationship Between Chronic OA Pain and Cognition Deficits in OA Patients.
NCT05570240
Effectiveness of Exercise Plus Pain Neuroscience Education on Brain Function in Knee Osteoarthritis
NCT06482970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Refrain from consuming cigarettes and caffeine 2 hours and 6 hours before testing, respectively
* Refrain from taking short-acting analgesics (e.g., acetaminophen) 6 hours before testing
Exclusion Criteria
* Having a diagnosis of neurological disorder or diagnosis of chronic pain (other knee OA)
* Having metal implants in the skull
* Having pacemaker or neurostimulator
* Being pregnant
* Being epileptic
50 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guillaume Léonard
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Leonard, Ph.D., pht.
Role: PRINCIPAL_INVESTIGATOR
Centre de Recherche sur le Vieillissement (CdRV)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de recherche sur le vieillissement (CdRV)
Sherbrooke, Quebec, Canada
CRCHUS: Centre de recherche du centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-454-IUGS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.